Our current portfolio of proprietary product
candidates includes the following:
We focus our drug discovery and development efforts on designing new chemical entities that treat major diseases.
Our unique, Transported Prodrug approach has yielded a robust product pipeline with multiple product candidates that may be effective in treating more than one disease state.